Mail: PO Box 900922 | Seattle, WA 98109, USA
Street: 2201 Westlake Avenue, Suite 200, Seattle, WA 98121
Tel: +1 206 285 3500
Prof. de Sanjosé’s research interests focus on studies of cancer-associated infectious diseases. She has studied the role of HPV in cervical carcinogenesis for more than 20 years. As part of the Cancer Epidemiology Research Programme at the Catalan Institute of Oncology, in Spain she has been involved in a wide range of activities devoted to understand the natural history of HPV infections and its burden worldwide. In the last 10+ years she coordinated a large international study on HPV genotyping in cancers of the cervix, vagina, vulva, penile and anal canal. Results are being very valuable to estimate the impact of HPV vaccines in the different world regions. She also contributed to several meta-analyses of compiled data from all over the world to characterize HPV genotype distribution, age trends, and time trends in relation to cervical cancer.
Silvia de Sanjosé has been closely involved on the ICO/IARC HPV Information Centre on HPV and Cervical Cancer, a web-based resource to compile and disseminate scientific data on HPV and related cancers from all world regions. She has also participated in several studies in Africa on HPV screening, vaccination and epidemiology in Tanzania, Burkina Faso, Ghana and South Africa. She is also coordinating and mentoring courses from the e_oncology learning platform, and is in particular involved in the Cervical Cancer Prevention courses and cancer basics for Community Health Workers in Africa.
Prof. de Sanjosé has been involved in the WHO HPV vaccines position paper in 2009, in the Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention issued in 2013 and the 11 volumes of the Vaccine monographs series aiming to review state of the art knowledge on HPV and related diseases.
Since 2018, Prof. de Sanjosé is Director of the Scale-up project for PATH.
As President of the International Papillomavirus Society in the last year and a half, the Society has undertaken major changes with the purpose to bring a structure helpful to their members. IPVS must continue to be the best platform to promote most solid research in its conferences on HPV research. I think IPVS must take a leading role in providing guidance for the implementation of preventive measures and in educational platforms on PV.